Oracle Co. (NYSE:ORCL) Stake Decreased by Private Wealth Partners LLC

Share on StockTwits

Private Wealth Partners LLC reduced its stake in shares of Oracle Co. (NYSE:ORCL) by 7.0% during the 1st quarter, HoldingsChannel.com reports. The fund owned 18,807 shares of the enterprise software provider’s stock after selling 1,418 shares during the period. Private Wealth Partners LLC’s holdings in Oracle were worth $1,010,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Investors Research Corp purchased a new position in Oracle in the first quarter valued at approximately $30,000. Riverview Trust Co purchased a new position in Oracle in the fourth quarter valued at approximately $35,000. Covenant Multifamily Offices LLC purchased a new position in Oracle in the first quarter valued at approximately $35,000. Truehand Inc purchased a new position in Oracle in the fourth quarter valued at approximately $36,000. Finally, ERTS Wealth Advisors LLC purchased a new position in Oracle in the fourth quarter valued at approximately $36,000. Institutional investors and hedge funds own 53.15% of the company’s stock.

In other news, insider Edward Screven sold 600,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $54.96, for a total transaction of $32,976,000.00. Following the completion of the sale, the insider now owns 2,812,345 shares of the company’s stock, valued at $154,566,481.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Mark V. Hurd sold 1,200,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $53.83, for a total transaction of $64,596,000.00. Following the sale, the chief executive officer now directly owns 1,664,227 shares of the company’s stock, valued at approximately $89,585,339.41. The disclosure for this sale can be found here. Insiders have sold 2,473,750 shares of company stock valued at $133,883,350 in the last three months. Corporate insiders own 32.00% of the company’s stock.

Shares of ORCL stock traded down $0.05 during mid-day trading on Wednesday, reaching $53.89. 1,106,869 shares of the company were exchanged, compared to its average volume of 13,351,675. Oracle Co. has a fifty-two week low of $42.40 and a fifty-two week high of $55.53. The company has a current ratio of 2.65, a quick ratio of 2.65 and a debt-to-equity ratio of 2.13. The company has a market capitalization of $182.02 billion, a P/E ratio of 19.11, a PEG ratio of 1.60 and a beta of 1.09.

Oracle (NYSE:ORCL) last released its quarterly earnings results on Thursday, March 14th. The enterprise software provider reported $0.78 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.02. Oracle had a net margin of 27.14% and a return on equity of 34.03%. The business had revenue of $9.62 billion during the quarter, compared to the consensus estimate of $9.59 billion. During the same quarter last year, the company earned $0.83 earnings per share. The business’s quarterly revenue was down .7% compared to the same quarter last year. On average, research analysts predict that Oracle Co. will post 3.09 EPS for the current year.

Several research analysts recently commented on ORCL shares. Credit Suisse Group set a $60.00 price target on shares of Oracle and gave the company a “buy” rating in a report on Monday, March 11th. Goldman Sachs Group restated a “buy” rating and issued a $55.00 price target on shares of Oracle in a report on Thursday, February 14th. Zacks Investment Research upgraded shares of Oracle from a “hold” rating to a “buy” rating and set a $61.00 price target on the stock in a report on Wednesday, May 15th. Morgan Stanley lifted their price objective on shares of Oracle from $54.00 to $59.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 21st. Finally, Standpoint Research lowered shares of Oracle from a “buy” rating to a “hold” rating in a research note on Tuesday, February 19th. Three research analysts have rated the stock with a sell rating, eighteen have issued a hold rating and eight have given a buy rating to the stock. Oracle presently has a consensus rating of “Hold” and an average price target of $53.11.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4369165/oracle-co-nyseorcl-stake-decreased-by-private-wealth-partners-llc.html.

Oracle Profile

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports application, platform, and infrastructure solutions for information technology (IT) environments worldwide. The company provides services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service.

Featured Story: Mutual Funds

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MetaMorph Trading Down 14.4% Over Last 7 Days
MetaMorph Trading Down 14.4% Over Last 7 Days
MSG Networks Inc  Expected to Announce Earnings of $0.61 Per Share
MSG Networks Inc Expected to Announce Earnings of $0.61 Per Share
Ondori  Market Cap Hits $3.07 Million
Ondori Market Cap Hits $3.07 Million
Napco Security Technologies Inc  Given $27.50 Average Target Price by Analysts
Napco Security Technologies Inc Given $27.50 Average Target Price by Analysts
Sharpay  Trading Up 2.3% Over Last 7 Days
Sharpay Trading Up 2.3% Over Last 7 Days
Comparing Coherus Biosciences  and Cortexyme
Comparing Coherus Biosciences and Cortexyme


© 2006-2019 Ticker Report